Insomnia affects 30-50% of adults with diabetes — roughly twice the rate in the general population. The relationship is bidirectional: poor sleep worsens insulin resistance and glucose control; diabetes complications and management challenges worsen sleep. Sleep loss affects glucose metabolism through reduced insulin sensitivity (even one night of poor sleep reduces sensitivity by 30-40%), elevated cortisol raising blood glucose, increased appetite for high-carb foods, and increased inflammation. Common causes of insomnia in diabetes include nocturia (frequent nighttime urination from poorly controlled blood sugar), neuropathy pain, hypoglycemia anxiety in adults on insulin, restless legs syndrome, sleep apnea (especially with type 2 diabetes), depression and anxiety, and some diabetes medications. Cognitive Behavioral Therapy for Insomnia (CBT-I) is the gold standard treatment — more effective long-term than medications, with improvements maintained at 1-year follow-up. CBT-I components include sleep restriction therapy, stimulus control, cognitive therapy for sleep anxieties, sleep hygiene, and relaxation training. Sleep medications can be useful but have considerations specific to diabetes — benzodiazepines and Z-drugs may mask hypoglycemia symptoms; anticholinergic medications increase fall risk.
How Sleep Affects Diabetes
- Insulin resistance increased by 30-40% with sleep deprivation.
- Elevated cortisol raises blood glucose.
- Increased appetite, particularly for high-carb foods next day.
- Disrupted growth hormone — affects glucose regulation.
- Reduced exercise capacity.
- Increased systemic inflammation (CRP, IL-6).
- Greater glycemic variability.
- Worsened A1C — 0.5-1.5 percentage points with chronic insomnia.
Common Causes in Diabetes
| Cause | Mechanism | Solution Approach |
|---|---|---|
| Nocturia | Frequent urination from hyperglycemia | Improve glycemic control |
| Neuropathy pain | Burning/tingling worse at night | Gabapentin, duloxetine |
| Hypoglycemia anxiety | Fear of nighttime lows | CGM with alarms; CBT |
| Sleep apnea | Common in T2D obesity | CPAP therapy |
| Restless legs syndrome | Common in diabetes/neuropathy | Iron evaluation, gabapentin |
| Depression | Common comorbidity | Treat depression |
| Diabetes medication | Steroids, some others | Discuss with prescriber |
CBT-I Components
- Sleep restriction: limit bed time to actual sleep duration; gradually increase.
- Stimulus control: bed only for sleep and sex; leave bed after 20 minutes awake.
- Cognitive therapy: address sleep-related anxieties and catastrophic thinking.
- Sleep hygiene: caffeine timing, screen time, alcohol, exercise patterns.
- Relaxation training: progressive muscle relaxation, deep breathing.
- Sleep diary tracking.
- Typically 6-8 weekly sessions; significant improvement by week 4.
- Apps with CBT-I components: Sleepio, Somryst, CBT-I Coach (free).
Sleep Hygiene Basics
- Consistent bedtime and wake time (even weekends).
- Bedroom cool (65-70°F), dark, quiet.
- No screens 30-60 minutes before bed.
- Limit caffeine after noon.
- Alcohol disrupts sleep — limit, especially within 3 hours of bed.
- Exercise regularly (but not within 2 hours of bedtime).
- Avoid large meals close to bedtime.
- Limit fluids 2 hours before bed (especially with nocturia).
- Bedroom for sleep only — not work, TV, scrolling.
- Brief outdoor sunlight exposure in morning helps circadian rhythm.
Sleep Medications with Diabetes
- Trazodone (50-100 mg) — commonly used; minimal glucose impact.
- Zolpidem (Ambien) — short-term; tolerance; rebound.
- Melatonin (1-10 mg) — minimal glucose impact; some adults respond well.
- Doxepin (Silenor) — for sleep maintenance; low-dose tricyclic.
- Suvorexant (Belsomra) — orexin antagonist; expensive.
- Ramelteon (Rozerem) — melatonin receptor agonist.
- Eszopiclone (Lunesta) — Z-drug; bitter taste.
- Avoid: long-term benzodiazepines (Xanax, Valium for sleep) — fall risk, dependence.
- Avoid: anticholinergic OTC (diphenhydramine, doxylamine) — fall risk, cognitive effects.
Hypoglycemia and Sleep
- Hypoglycemia anxiety is real and impairs sleep.
- Continuous glucose monitor (CGM) with alarm features reduces anxiety.
- Bedtime snack with protein/fat for adults at hypoglycemia risk.
- Have glucose tabs at bedside.
- Educate partners about hypoglycemia signs.
- Adjust insulin doses with healthcare provider to prevent overnight lows.
- Set CGM alarm at slightly higher threshold for warning before severe low.
- For severe hypoglycemia history: glucagon emergency kit at bedside.
The Bottom Line
Insomnia affects 30-50% of adults with diabetes — roughly twice the rate in the general population. The relationship is bidirectional: poor sleep worsens insulin resistance and glucose control (one night of poor sleep reduces insulin sensitivity by 30-40%); diabetes complications and management challenges worsen sleep. Common causes in diabetes include nocturia from poorly controlled blood sugar, neuropathy pain, hypoglycemia anxiety, restless legs syndrome, sleep apnea, depression, and some medications. Untreated insomnia worsens A1C by 0.5-1.5 percentage points. Cognitive Behavioral Therapy for Insomnia (CBT-I) is the gold standard treatment — more effective long-term than medications, with improvements maintained at 1-year follow-up. CBT-I components: sleep restriction therapy, stimulus control, cognitive therapy for sleep anxieties, sleep hygiene, and relaxation training. Apps with CBT-I components include Sleepio, Somryst, and CBT-I Coach. Sleep hygiene fundamentals: consistent schedule, cool dark quiet bedroom, no screens 30-60 minutes before bed, limit caffeine after noon, avoid alcohol close to bedtime, exercise regularly. Sleep medications with diabetes considerations: trazodone (low-dose), melatonin, doxepin, suvorexant, zolpidem (short-term). Avoid long-term benzodiazepines and anticholinergic OTC (diphenhydramine) — fall risk, cognitive effects. For hypoglycemia anxiety, CGM with alarms substantially helps; keep glucose tabs at bedside; educate partners. See our broader sleep and diabetes guide for context.
